Understanding how prostate cancer changes and becomes resistant to treatment
Molecular mechanisms underlying lineage plasticity in prostate cancer
This study is looking at how prostate cancer can change and become tougher to treat, so we can find new ways to help patients with advanced prostate cancer.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10976686 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which prostate cancer can change its characteristics and become resistant to therapies that target the androgen receptor. It focuses on how tumors can lose their typical prostate identity and adopt new traits that make them harder to treat. By analyzing patient data and laboratory models, the research aims to identify specific genes and pathways involved in this process, which could lead to new treatment strategies for patients with advanced prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with advanced prostate cancer who are experiencing resistance to androgen receptor-targeted therapies.
Not a fit: Patients with early-stage prostate cancer who have not yet undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with androgen-resistant prostate cancer.
How similar studies have performed: Other research has shown promise in understanding lineage plasticity in cancer, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Beltran, Himisha — Dana-Farber Cancer Inst
- Study coordinator: Beltran, Himisha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.